Download PDFPDF
Low influenza-vaccination rate among adults receiving immunosuppressive therapy for systemic inflammatory disease
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Comment on article by Lanternier
    • Clive A Kelly, consultant physician
    • Other Contributors:
      • Madeleine Housden, Gillian Bell, Jennifer Hamilton and Clive Kelly

    Dear Sir

    We write in response to a recent letter in the Annals describing a low vaccination rate among adults with systemic inflammatory disease [1].
    Lanternier et al reported vaccination rates of 57% among patients with rheumatoid arthritis (RA) and found that the biggest barrier to vaccination was the failure of medical staff to recommend it! The authors conclude that all such patients should be tar...

    Show More
    Conflict of Interest:
    None declared.